Related Experiment Video

Updated: May 17, 2026

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

Clostridium difficile infection: new insights into management

Sahil Khanna1, Darrell S Pardi

  • 1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA.

Mayo Clinic Proceedings
|November 7, 2012
PubMed

Insights

Clostridium difficile infection (CDI) is a growing threat, with rising rates and severity. Emerging treatments like fecal microbiota transplantation offer new hope for managing this challenging hospital-acquired infection.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Epidemiology

Background:

  • Clostridium difficile infection (CDI) is a leading cause of hospital-acquired infections in the US.
  • CDI incidence, severity, and recurrence rates have increased significantly over the past two decades.
  • Increased CDI rates are associated with poorer patient outcomes.

Purpose of the Study:

  • To review the evolving epidemiology of Clostridium difficile infection.
  • To identify novel risk factors contributing to CDI.
  • To discuss emerging and promising treatment strategies for CDI.

Main Methods:

  • Literature review focusing on recent studies and clinical data.
  • Analysis of epidemiological trends and risk factor identification.
  • Evaluation of novel therapeutic interventions for CDI.

Main Results:

  • CDI remains a significant healthcare-associated pathogen with increasing challenges.
  • New risk factors are being identified, contributing to the complexity of CDI.
  • Promising new treatments include fidaxomicin, monoclonal antibodies, and fecal microbiota transplantation.

Conclusions:

  • Clostridium difficile infection presents an escalating public health concern.
  • Understanding changing epidemiology and risk factors is crucial for effective prevention and treatment.
  • Novel therapies demonstrate potential for improved CDI management and outcomes.

More Related Videos

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R2029106:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs like...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...